Implementation of a Multi-Cancer Early Detection (MCED) Test in a Private Practice: Adoption, Performance, and Repeat-Testing Patterns Brandon Morse Implementation of a Multi-Cancer Early Detection (MCED) Test in a Private Practice: Adoption, Performance, and Repeat-Testing Patterns Read More »
Safety and Performance Results From PATHFINDER 2 (PF2), a Registrational Study of a Multi-Cancer Early Detection (MCED) Test in an Intended-Use Population Brandon Morse Safety and Performance Results From PATHFINDER 2 (PF2), a Registrational Study of a Multi-Cancer Early Detection (MCED) Test in an Intended-Use Population Read More »
NHS-Galleri: Primary Results From a Randomised Controlled Trial to Assess the Clinical Utility of a Multi-Cancer Early Detection (MCED) Test in Population Screening Brandon Morse NHS-Galleri: Primary Results From a Randomised Controlled Trial to Assess the Clinical Utility of a Multi-Cancer Early Detection (MCED) Test in Population Screening Read More »
Prognostic significance of blood-based multi-cancer detection in circulating tumor DNA (ctDNA): 5-year outcomes analysis Grail Content Editor Prognostic significance of blood-based multi-cancer detection in circulating tumor DNA (ctDNA): 5-year outcomes analysis Read More »
Impact of Negative Cancer Screening Results on Patient-Reported Outcomes and Behavioral Intentions Grail Content Editor Impact of Negative Cancer Screening Results on Patient-Reported Outcomes and Behavioral Intentions Read More »
Diagnostic Test Use and Time to Cancer Diagnosis in Medicare Recipients Grail Content Editor Diagnostic Test Use and Time to Cancer Diagnosis in Medicare Recipients Read More »
Multi-Cancer Early Detection (MCED) Test Performance in Cancer Survivors Grail Content Editor Multi-Cancer Early Detection (MCED) Test Performance in Cancer Survivors Read More »
Overall and Non-Lung Cancer Incidence in the National Lung Screening Trial (NLST) as Indicators of Potential for Multi-Cancer Screening Grail Content Editor Overall and Non-Lung Cancer Incidence in the National Lung Screening Trial (NLST) as Indicators of Potential for Multi-Cancer Screening Read More »
Examining the Potential for Lead-Time Bias by Estimating Stage-Specific Proportions of Deaths Due to Diagnosed Cancer Grail Content Editor Examining the Potential for Lead-Time Bias by Estimating Stage-Specific Proportions of Deaths Due to Diagnosed Cancer Read More »
Methylated DNA Biomarkers and Incident Cancer in the American Cancer Society (ACS) Cancer Prevention Study-3 (CPS-3) Cohort Grail Content Editor Methylated DNA Biomarkers and Incident Cancer in the American Cancer Society (ACS) Cancer Prevention Study-3 (CPS-3) Cohort Read More »
